Cite
HARVARD Citation
Jane, E. et al. (2022). Reversing tozasertib resistance in glioma through inhibition of pyruvate dehydrogenase kinases. Molecular oncology. 16 (1), pp. 219-249. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jane, E. et al. (2022). Reversing tozasertib resistance in glioma through inhibition of pyruvate dehydrogenase kinases. Molecular oncology. 16 (1), pp. 219-249. [Online].